Cardinal Health, Inc. (CAH)

Market Cap	49.99B +55.5%
Revenue (ttm)	244.67B +10.1%
Net Income	1.66B +26.7%
EPS	6.94 +29.5%
Shares Out	235.32M
PE Ratio	30.62
Forward PE	19.58
Dividend	$2.04 (0.96%)
Ex-Dividend Date	Apr 1, 2026

Volume	553,206
Open	211.37
Previous Close	212.62
Day's Range	210.39 - 214.14
52-Week Range	120.72 - 233.60
Beta	0.65
Analysts	Buy
Price Target	230.45 (+8.47%)
Earnings Date	Apr 30, 2026

About CAH

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products....

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1979
• Employees: 57,700
• Stock Exchange: NYSE
• Ticker Symbol: CAH
• Website: https://www.cardinalhealth.com

Financial Performance

In fiscal year 2025, Cardinal Health's revenue was $222.58 billion, a decrease of -1.87% compared to the previous year's $226.83 billion. Earnings were $1.56 billion, an increase of 83.22%.

Analyst Summary

According to 11 analysts, the average rating for CAH stock is "Buy." The 12-month stock price target is $230.45, which is an increase of 8.47% from the latest price.

Price Target

$230.45

(8.47% upside)

Analyst Consensus: Buy